Pittsburgh compound B positron emission tomography detects cardiomyopathy in hereditary transthyretin amyloidosis patients with negative bone scintigraphy: a pilot study
[<sup>11</sup>C]PiB PET could be an effective tool for detecting ATTR cardiomyopathy in patients with <i>TTR</i> variants associated with reduced bone scintigraphy sensitivity. However, its utility for detecting brain involvement in symptomatic hereditary ATTR patients remains uncertain.
Authors
- Paul Van Snick
- Gilles N. Stormezand (ORCID: https://orcid.org/0000-0002-1370-8791)
- Bouke P. C. Hazenberg (ORCID: https://orcid.org/0000-0003-1827-0482)
- Y. Hu
- Paul A. van der Zwaag (ORCID: https://orcid.org/0000-0001-6693-0321)
- G. Luurtsema
- Hans L A Nienhuis
- Hendrea S A Tingen
- P Van Der Meer
- Marish Oerlemans
- Riemer H. J. A. Slart
Institutions
- University Medical Center Groningen (NL)
- University Medical Center Utrecht (NL)
- ERN GUARD-Heart (NL)
- University of Twente (NL)
Publication Details
- Journal
- Frontiers in Nuclear Medicine
- Published
- 2026-02-09
- DOI
- https://doi.org/10.3389/fnume.2026.1747625
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00